News

Application scenarios of silicon carbide replacing ferrosilicon

In the high-temperature metallurgical fields such as steel and casting, ferrosilicon has been used as a traditional deoxidizer and alloying agent for many years. However, with the increasing pressure on environmental protection and innovations in material technology, silicon carbide (SiC) is gradually becoming an ideal substitute for ferrosilicon due to its high efficiency and low emission characteristics.

Plant Extract Export Cooperation and Quality Assurance

A European health supplement company planned to develop natural plant health products and sought a high-quality plant extract supplier. Leveraging its years of experience in plant extract R&D and production, our company provided a variety of plant extract samples that met EU standards and optimized the extraction process to meet the client's requirements, ensuring consistent active ingredient content. Throughout the collaboration, we strictly adhered to international quality standards, ensuring each batch of product passed third-party testing. The company successfully achieved monthly plant extract exports of 10 tons, helping the client expand into the European natural health supplement market.

One-Stop Supply Service for Daily Chemical Raw Materials

A large daily chemical company launched a new line of hair care products and needed to procure a variety of daily chemical raw materials. Based on the client's needs, the company integrated its own production and partner factory resources to provide a one-stop service, from raw material screening, sample testing, to batch supply. In response to the client's high requirements for raw material safety and stability, quality inspection reports were issued throughout the process to ensure that the 500 tons of daily chemical raw materials supplied met industry standards, helping the client shorten product development cycles and quickly bring them to market.

Technology Upgrade and Mass Production of Anti-tumor Pharmaceutical Intermediates

To meet market demand for highly effective, low-toxic anti-tumor drugs, the company invested in R&D to upgrade the technology of a specific anti-tumor pharmaceutical intermediate. By optimizing the reaction route and improving the production process, the company not only reduced production costs by 30% but also controlled the product impurity content to below 0.1%. The technological upgrade enabled large-scale mass production, supplying 20 tons of high-quality anti-tumor pharmaceutical intermediates to downstream pharmaceutical companies monthly, helping to increase the production capacity of multiple anti-tumor drugs.